Laurus Labs hits record high; rallies 17% in 7 days post Q1 results
The management holds a positive outlook across all four businesses -- FDF, APIs, Synthesis and Bio -- and believes the outlook remains robust driven by improving demand and supported by capex
No comments:
Post a Comment